Condor Capital Management Gsk PLC Transaction History

Condor Capital Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$38.88 - $45.31 $760,687 - $886,490	-19,565 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$42.0 - $48.25 $14,952 - $17,177	-356 Reduced 1.79%	19,565 $919,000
Q3 2019 Nov 06, 2019	SELL	$40.46 - $43.52 $14,403 - $15,493	-356 Reduced 1.76%	19,921 $850,000
Q3 2018 Nov 01, 2018	BUY	$39.75 - $42.69 $79 - $85	2 Added 0.01%	20,277 $815,000
Q2 2018 Aug 01, 2018	SELL	$39.61 - $42.76 $14,101 - $15,222	-356 Reduced 1.73%	20,275 $817,000
Q3 2017 Nov 08, 2017	BUY	$39.44 - $41.55 $813,686 - $857,218	20,631	20,631 $838,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.5B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Condor Capital Management, based on Form 13F filings with the SEC.

Stay updated on Condor Capital Management with notifications on news.